新曙光
疾病早期拦截
聚焦


MiRXES announced today that Dr. Lihan ZHOU, Co-founder and Chief Executive Officer at MiRXES, Dr. Ruiyang ZOU, Co-founder and Chief Technology Officer at MiRXES and Mr. Isaac HO, Chief Investment Officer at MiRXES, have been named EY Entrepreneur Of The Year (EOY) 2021 Singapore by professional services organization, EY.
Learn More

At-home cancer tests that could detect the disease even in the absence of symptoms? They could very well be a possibility in the future.
Dr Zhou is the Chief Executive Officer of MiRXES, a biotechnology company he co-founded with Chief Technology Officer Dr Zou Ruiyang, that specialises in producing polymerase chain reaction (PCR) tests to detect early stage cancer. The company brings to life his vision, running with the ethos that prevention is better than cure, and that early detection enables early interception, leading to early treatment and subsequently, saved and improved lives.


Whenever we fall sick, we often associate each illness with a characteristic set of symptoms. Constantly sneezing with a bad rash? Must be allergies. Stuffy nose and sore throat? Likely the flu. Bloodshot eyes? Likely conjunctivitis or pink eye. But not all diseases come with obvious symptoms.
提供我们的解决方案
当今世界有四分之一的人罹患癌症。在 MiRXES,我们深知科学技术在抗击癌症中的重要性。我们明白,为了在改善和挽救生命方面发挥最大作用,必须将我们的创新解决方案从实验室带到临床上。
请阅读更多关于我们解决方案的信息,从我们领先业界的检测工具和服务到癌症、心血管疾病、代谢疾病和传染病的诊断检查,再到精准肿瘤学,了解这些解决方案能使您在最重要的时刻采取更迅速的行动。
